Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazoneâ„¢ (MSDC-0160) in Type 2 Diabetic Patients
| Status: | Archived |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2010 |
| End Date: | June 2011 |
A Phase 2B, Randomized, Double-Blind, Comparator- and Placebo-Controlled, Dose Ranging Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazoneâ„¢ in Type 2 Diabetic Patients
The purpose of this study is to evaluate the safety, tolerability and efficacy of three dose
levels of Mitoglitazoneâ„¢ (MSDC-0160) in patients with type 2 diabetes.
We found this trial at
12
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials